What does stable disease mean on my Endometrial Cancer scan results
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding "Stable Disease" on Your Endometrial Cancer Scan
Great question—this is an important term to understand. Let me break down what "stable disease" means and what it tells you about your cancer status.
What "Stable Disease" Means
Stable disease means that the cancer hasn't significantly changed in size or appearance since your last scan. Specifically:
- No growth: The tumors are not getting larger
- No shrinkage: The tumors are not getting smaller
- No new lesions: No new areas of cancer have appeared
- Consistent appearance: The existing cancer looks similar to the previous imaging
Think of it like a "holding pattern"—your cancer isn't progressing forward, but it's also not responding with visible shrinkage.
How Doctors Measure This
Radiologists use specific measurement criteria to determine stable disease. They typically:
- Measure existing tumors on your current scan and compare them to previous scans
- Look for new areas of cancer spread
- Assess the appearance of known tumors (density, shape, characteristics)
- Use standardized guidelines (like RECIST criteria) to define what counts as "stable" versus "growing" or "shrinking"
Generally, a tumor needs to grow by about 20% or more to be called "progressive disease" (growing cancer), and needs to shrink by about 30% or more to be called a "response" (shrinking cancer).
What This Means for Your Treatment
According to NCCN Guidelines for Endometrial Carcinoma, imaging surveillance is guided by your symptoms, risk factors, and clinical concerns. Stable disease findings typically mean:
- Your current treatment is holding the cancer in check (not making it worse)
- Your doctor may continue your current treatment plan if you're tolerating it well
- You may need continued monitoring with follow-up scans at regular intervals to ensure it remains stable
- Your care team will assess whether adjustments are needed based on your overall clinical picture, symptoms, and how you're tolerating treatment
Important Context Questions to Ask Your Doctor
Since stable disease can mean different things depending on your specific situation, here are key questions to discuss with your oncology team:
-
"Is stable disease considered a good response to my current treatment, or should we consider changing my treatment plan?"
-
"How long do you expect the disease to remain stable, and what signs should I watch for that might indicate change?"
-
"What is the plan for monitoring—how often will I have follow-up scans, and what will trigger a change in treatment?"
-
"Are there any other factors (like tumor markers, symptoms, or molecular characteristics) that influence how we interpret this stable disease result?"
-
"If the disease remains stable, is there a long-term treatment plan, or will we reassess at a certain point?"
The Bigger Picture
Stable disease is generally considered better than progressive disease (cancer growing), but not as favorable as a response (cancer shrinking). However, the clinical significance depends on:
- Your baseline status when you started treatment
- How long it remains stable (longer is generally better)
- Your symptoms and quality of life during treatment
- Your overall health and ability to tolerate ongoing therapy
- The specific type and stage of your endometrial cancer
According to NCCN Guidelines, post-treatment surveillance for endometrial cancer is individualized based on your risk factors and clinical presentation. If you're on active treatment, your oncologist will determine the appropriate imaging schedule and whether stable disease warrants continuing, modifying, or changing your current approach.
Next Steps
Make sure to:
- Bring your scan report to your next appointment
- Ask your doctor to explain what "stable" means specifically for YOUR cancer
- Discuss the treatment plan going forward
- Clarify the monitoring schedule so you know when to expect follow-up scans
- Report any new symptoms between scans, as these can be important even if imaging appears stable
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with clinical trials for Endometrial Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: